These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


252 related items for PubMed ID: 17448287

  • 1. [Study of treatment of hyaline membrane disease with pulmonary surfactant replacement in premature infant].
    Ji SP, Zhang XL, Ma WX, Sun YP, Li XH, Yu JH.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr; 19(4):248. PubMed ID: 17448287
    [No Abstract] [Full Text] [Related]

  • 2. Pulmonary surfactant and its clinical application.
    Jin HZ.
    Chin Med J (Engl); 1991 Mar; 104(3):225-7. PubMed ID: 2065535
    [No Abstract] [Full Text] [Related]

  • 3. Surfactant replacement therapy in newborns with hyaline membrane disease.
    Grobman DW, Foley MM.
    Crit Care Nurs Clin North Am; 1992 Sep; 4(3):515-20. PubMed ID: 1388997
    [Abstract] [Full Text] [Related]

  • 4. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
    Lozano-González CH, Piña-Ceballos VM, Beyer-Obezo J, Gutiérrez-Martín A, Martínez-Hinojosa B, Flores-Támez ME.
    Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
    [Abstract] [Full Text] [Related]

  • 5. A model of the effect of surfactant treatment on gas exchange in hyaline membrane disease.
    Cotton RB.
    Semin Perinatol; 1994 Feb; 18(1):19-22. PubMed ID: 8209282
    [No Abstract] [Full Text] [Related]

  • 6. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome.
    Teksam O, Kale G.
    Pathol Res Pract; 2009 Feb; 205(1):35-41. PubMed ID: 18951732
    [Abstract] [Full Text] [Related]

  • 7. [Administration of surfactant in hyaline membrane disease].
    Valls i Soler A.
    An Esp Pediatr; 1987 Sep; 27(3):147-51. PubMed ID: 3322119
    [No Abstract] [Full Text] [Related]

  • 8. The effectiveness and cost of exogenous pulmonary surfactant replacement therapy.
    Smith J, Pieper C, Gie RP.
    S Afr Med J; 1995 Nov; 85(11):1192, 1195-6. PubMed ID: 8597017
    [No Abstract] [Full Text] [Related]

  • 9. Neonatal surfactant replacement therapy. Fetus and Newborn Committee, Canadian Paediatric Society.
    CMAJ; 1992 Apr 15; 146(8):1309-12. PubMed ID: 1555161
    [No Abstract] [Full Text] [Related]

  • 10. [Factors increasing susceptibility to neonatal hyaline membrane syndrome and its prevention. I. Deficiency of surfactant and glucocorticoid treatment].
    Uszyńska-Folejewska R, Uszyński M.
    Pediatr Pol; 1977 Dec 15; 52(12):1413-7. PubMed ID: 343058
    [No Abstract] [Full Text] [Related]

  • 11. Surfactant therapy for hyaline membrane disease: the Chandigarh experience.
    Narang A, Kumar P, Dutta S, Kumar R.
    Indian Pediatr; 2001 Jun 15; 38(6):640-6. PubMed ID: 11418729
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of hyaline membrane disease by human amniotic fluid surfactant.
    Jin HZ, Chen C, Jin QL, Shao XM.
    Chin Med J (Engl); 1989 Dec 15; 102(12):944-6. PubMed ID: 2517741
    [Abstract] [Full Text] [Related]

  • 14. [Pulmonary hyaline membranes in newborn infants. (Idiopathic respiratory distress syndrome)].
    Göcke H, Bienengräber A.
    Zentralbl Chir; 1974 Aug 23; 99(34):1057-61. PubMed ID: 4613061
    [No Abstract] [Full Text] [Related]

  • 15. Hyaline membrane disease treated with bovine surfactant.
    Smyth JA, Metcalfe IL, Duffty P, Possmayer F, Bryan MH, Enhorning G.
    Pediatrics; 1983 Jun 23; 71(6):913-7. PubMed ID: 6687937
    [Abstract] [Full Text] [Related]

  • 16. [Exogenous surfactants].
    Dehan M, Denizot B.
    Arch Fr Pediatr; 1989 Feb 23; 46(2):85-7. PubMed ID: 2660764
    [No Abstract] [Full Text] [Related]

  • 17. Replacement of surfactant in hyaline membrane disease.
    Cottrell RC, Miller K.
    Br Med J (Clin Res Ed); 1984 Nov 17; 289(6455):1381-2. PubMed ID: 6437561
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of hyaline membrane disease by administration of exogenous surfactant].
    Bonte F, Dehan M, de Fontanges A, Lindenbaum A, Perret L, Puisieux F.
    Arch Fr Pediatr; 1985 May 17; 42(5):397-402. PubMed ID: 3907577
    [No Abstract] [Full Text] [Related]

  • 19. Surfactant replacement therapy. Innovative care for the premature infant.
    Miller EP, Armstrong CL.
    J Obstet Gynecol Neonatal Nurs; 1990 May 17; 19(1):14-7. PubMed ID: 2299437
    [Abstract] [Full Text] [Related]

  • 20. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods.
    Chotigeat U, Promwong N, Kanjanapattanakul W, Khorana M, Sangtawesin V, Horpaopan S.
    J Med Assoc Thai; 2008 Oct 17; 91 Suppl 3():S109-14. PubMed ID: 19253505
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.